DGAP-News: Hannover Re makes a good start to the 2014

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
DGAP-News: Hannover Re makes a good start to the 2014 financial year

DGAP-News: Hannover Rück SE / Key word(s): Quarter Results Hannover Re makes a good start to the 2014 financial year 07.05.2014 / 07:00 --------------------------------------------------------------------- Press release Hannover Re makes a good start to the 2014 financial year - Return on equity: 15.3% - Combined ratio: 94.4% (94.0%) - Net major loss expenditure at a moderate EUR 30.6 million - Investment income +1.8%: EUR 361.2 million (EUR 354.7 million) - Group net income +0.7%: EUR 233.0 million (EUR 231.2 million) - Gross premium income: -0.7% adjusted for exchange rate effects Hannover, 7 May 2014: Hannover Re is satisfied with the development of its business in the first three months of 2014. "The quarterly profit of EUR 233 million was driven by a very pleasing underwriting result in non-life reinsurance and good investment income. This shows that we have adjusted well to the challenging business environment", Chief Executive Officer Ulrich Wallin commented. On the basis of this successful start to 2014, Hannover Re reaffirms its net income guidance in the order of EUR 850 million for the full financial year. Slight decline in gross premium Gross written premium for the Hannover Re Group contracted by 3.6% as at 31 March 2014 to EUR 3.6 billion (EUR 3.8 billion). At constant exchange rates the decrease would have been just 0.7%. The level of retained premium fell slightly to 88.4% (89.9%). Net premium earned consequently declined by a somewhat more marked 5.5% to EUR 2.9 billion (EUR 3.1 billion). The decrease amounted to 2.6% after adjustment for exchange rate effects. Pleasing Group net income The operating profit (EBIT) of EUR 349.6 million as at 31 March 2014 was on a similarly high level to the previous year (EUR 366.5 million). Group net income improved further on the comparable period of the previous year by a modest 0.7% to EUR 233.0 million (EUR 231.2 million). Earnings per share amounted to EUR 1.93 (EUR 1.92). Non-life reinsurance delivers very satisfactory profit contribution Non-life reinsurance continues to be fiercely competitive; this was also evident in the treaty renewals as at 1 January 2014. Hannover Re showed discipline in maintaining its profit-oriented underwriting policy and in so doing accepted modest declines in premium volume. Total gross premium for non-life reinsurance contracted by 4.1% as at 31 March 2014 relative to the comparable period to stand at EUR 2.1 billion (EUR 2.2 billion). At constant exchange rates the decrease would have been just 1.7%. The retention increased to 91.2% (89.8%), as a consequence of which net premium earned fell less sharply by 3.6% - or 1.0% adjusted for exchange rate effects - to EUR 1.6 billion (EUR 1.7 billion). Major loss expenditure was below average in the first three months of 2014, just as it had been in the corresponding quarter of the previous year. The only major loss resulted from the crash of the Malaysian passenger plane, wreckage of which had still to be located at time of going to press. Hannover Re has set aside reserves of EUR 30.6 million for this event; net major loss expenditure in the comparable quarter had amounted to EUR 13.4 million. "As in the past, the unused portion of the major loss budget was not released to income, but was allocated to the corresponding loss reserves - leaving us very well equipped to cope with any major losses in the remaining quarters of 2014", Mr. Wallin emphasised. The underwriting result again closed at a thoroughly pleasing EUR 87.6 million (EUR 98.1 million). Another very good combined ratio of 94.4% (94.0%) was recorded. In view of the very healthy underwriting result and a good contribution from the investment side, the operating profit (EBIT) in non-life reinsurance moved substantially higher by 8.4% to EUR 280.5 million (EUR 258.7 million). Group net income climbed a further 13.1% to EUR 197.9 million, building on the very good figure of EUR 174.9 million reported in the comparable period. Earnings per share stood at EUR 1.64 (EUR 1.45). Life and health reinsurance in line with expectations Life and health reinsurance is also the scene of increasingly intense competition. Although the targeted growth consequently failed to materialise in the first quarter, Hannover Re sees promising growth impulses for the rest of the year. This continues to be the case with emerging markets such as China, Brazil and India. Developments in Sharia-compliant retakaful business were particularly pleasing in the quarter just ended. In this segment Hannover Re focuses on Middle and Far Eastern markets and now ranks among the largest providers in the world. Gross premium for life and health reinsurance fell by 2.8% as at 31 March 2014 to EUR 1.5 billion (EUR 1.6 billion). At constant exchange rates, on the other hand, growth of 0.7% would have been booked. Reflecting a reduced level of retained premium, net premium earned retreated by 7.8% to EUR 1.3 billion (EUR 1.4 million); this is equivalent to a reduction of 4.5% after adjustment for exchange rate effects. In terms of profitability, life and health reinsurance fell short of the aperiodic high comparable figure of the previous year but still posted a satisfactory result. The operating profit (EBIT) in life and health reinsurance as at 31 March 2014 totalled EUR 65.6 million (EUR 102.4 million). Group net income came in at EUR 43.4 million (EUR 75.1 million); earnings per share amounted to EUR 0.36 (EUR 0.62). Thoroughly satisfactory investment income The investment environment remained challenging in the period under review. Although the portfolio of investments under own management declined slightly to EUR 31.7 billion (31 December 2013: EUR 31.9 million), this reflected the repurchase of the EUR 750 million bond issued in 2004 as well as exchange rate effects. Had it not been for these factors, assets under own management would have increased on the back of the continued clearly positive operating cash flow and rising valuation reserves. Despite the sustained low level of interest rates, ordinary investment income excluding interest on funds withheld and contract deposits was on a par with the previous year at EUR 241.4 million (EUR 246.1 million). Interest on funds withheld and contract deposits retreated slightly to EUR 88.6 million (EUR 93.8 million). The realised gains of EUR 54.1 million came in higher than in the comparable period (EUR 34.8 million). This increase can be attributed to the bond repurchase as well as to portfolio regrouping measures connected with the changeover in reporting currency from EUR to USD at the subsidiary in Bermuda. Changes in the fair values of financial instruments measured at profit or loss - the so-called ModCo derivatives and the inflation swaps are included here - totalled EUR 7.4 million (EUR 3.3 million) in the first quarter. Only very minimal write-downs had to be taken in the period under review. Income from assets under own management climbed by a very pleasing 4.5% as at 31 March 2014 to EUR 272.5 million (EUR 260.9 million). The resulting annualised return on investment came in above expectations at 3.4% (3.2%). Net investment income including interest on funds withheld and contract deposits closed higher than in the comparable quarter at EUR 361.2 million (EUR 354.7 million). Shareholders' equity remains robust Hannover Re's shareholders' equity grew by 7.0% to EUR 6.3 billion (31 December 2013: EUR 5.9 billion). The annualised return on equity increased to 15.3% (15.0%) despite the higher shareholders' equity and thus comfortably surpassed the minimum target of 750 basis points above the risk-free interest rate. The book value per share reached a new all-time high of EUR 52.26 (EUR 48.83). Outlook 2014 With the results reported as at 31 March 2014 Hannover Re has put in place a good initial foundation for attainment of its 2014 annual targets. Based on constant exchange rates, the company continues to expect stable to slightly higher gross premium and net income after tax in the order of EUR 850 million for the full 2014 financial year. This is conditional on major loss expenditure not significantly exceeding the anticipated level of EUR 670 million and assumes that there are no unforeseen adverse developments on capital markets. The continued challenging state of the general business environment was further evidenced by the renewals as at 1 April 2014, the traditional date for treaty renewals in Japan along with smaller markets in Korea, Australia, New Zealand as well as parts of US property catastrophe business. After the appreciable rate increases of recent years in Japan following the severe earthquake of 2011, initial rate erosion - albeit from a high level - was observed for catastrophe covers. Prices also declined in personal accident insurance. Rates for per-risk property covers, on the other hand, remained stable; in casualty business it was even possible to obtain modest increases. Overall, the premium volume in Japan contracted slightly, although Hannover Re was able to hold its market position thank to its long-standing client relationships. The company was similarly broadly satisfied with the outcome of its renewals in Australia and New Zealand. Treaties in Korea are shifting from a 1 April to a 1 January renewal date, as a consequence of which only a small part of the business was renewed. Faced with difficult market conditions Hannover Re consolidated its portfolio here. Broadly speaking, Hannover Re will continue to focus on preserving the profitability of its business in non-life reinsurance, even if this means a modest decrease in premium volume. "We take the view that this is the only way to ensure a profitable non-life reinsurance portfolio in the prevailing soft market", Mr. Wallin emphasised. Nevertheless, Hannover Re also sees growth opportunities in non-life reinsurance. Particularly noteworthy here are the Asia-Pacific markets, the countries of Central and Eastern Europe, marine lines as well as facultative business and structured reinsurance products. Adjusted for exchange rate effects, the premium volume for 2014 in non-life reinsurance should remain largely stable. Hannover Re expects to see an improved business development in life and health reinsurance. Growth prospects are especially evident in the emerging economies of Eastern Europe, Asia and Latin America, where stronger demand for protection products is being driven by a consistently expanding middle class. Gross premium for the full 2014 financial year is expected to show currency-adjusted growth in the low- to mid-single-digit percentage range. Hannover Re's targeted full-year return on investment remains unchanged at 3.2%. The company is not currently planning to make any significant adjustments to the allocation of its investments to individual asset classes. As for the dividend, the company continues to aim for a payout ratio in the range of 35% to 40% of its IFRS Group net income after tax. For further information please contact: Corporate Communications: Karl Steinle (tel. +49 511 5604-1500, e-mail: karl.steinle@hannover-re.com) Media Relations: Gabriele Handrick (tel. +49 511 5604-1502, e-mail: gabriele.handrick@hannover-re.com) Investor Relations: Julia Hartmann (tel. +49 511 5604-1529, e-mail: julia.hartmann@hannover-re.com) Please visit: www.hannover-re.com Hannover Re, with a gross premium of EUR 14.0 billion, is the third-largest reinsurer in the world. It transacts all lines of non-life and life and health reinsurance and is present on all continents with around 2,400 staff. The rating agencies most relevant to the insurance industry have awarded Hannover Re very strong insurer financial strength ratings (Standard & Poor's AA- "Very Strong" and A.M. Best A+ "Superior"). Please note the disclaimer: www.hannover-re.com/misc/disclaimer-pr-050811 Key figures of the Hannover Re Group (IFRS basis) <pre> +/- previous in EUR million Q1/2014 year Q1/2013(1) 2013 Hannover Re Group Gross written premium 3,624.4 (3.6%) 3,757.9 Net premium earned 2,912.7 (5.5%) 3,080.9 Net underwriting result 02. Mai (92.0%) 31.4 Net investment income 361.2 +1.8% 354.7 Operating profit (EBIT) 349.6 (4.6%) 366.5 Group net income 233.0 +0.7% 231.2 Earnings per share in EUR Jan 93 +0.7% Jan 92 Retention 88.4% 89.9% Tax ratio 19.4% 25.8% EBIT margin(2) 12.0% 11.9% Return on equity 15.3% 15.0% +/- previous in EUR million Q1/2014 year Q1/2013 2013 Policyholders' surplus 8,431.2 (3.8%) 8,767.9 Investments (excl. funds held by ceding companies) 31,738.6 (0.4%) 31,875.2 Total assets 54,328.8 +0.8% 53,915.5 Book value per share in EUR 52.26 +7.0% 48.83 Non-life reinsurance +/- previous in EUR million Q1/2014 year Q1/2013 2013 Gross written premium 2,107.8 (4.1%) 2,197.6 Net premium earned 1,631.7 (3.6%) 1,691.9 Net underwriting result 87.6 (10.7%) 98.1 Operating profit (EBIT) 280.5 +8.4% 258.7 Group net income 197.9 +13.1% 174.9 Retention 91.2% 89.8% Combined Ratio(3) 94.4% 94.0% EBIT margin(2) 17.2% 15.3% Life and health reinsurance +/- previous in EUR million Q1/2014 year Q1/2013(1) 2013 Gross written premium 1,516.7 (2.8%) 1,560.3 Net premium earned 1,281.0 (7.8%) 1,388.9 Operating profit (EBIT) 65.6 (36.0%) 102.4 Group net income 43.4 (42.2%) 75.1 Retention 84.5% 90.0% EBIT margin(2) 5.1% 7.4% </pre> (1) Adjusted on the basis of IAS 8 (2) Operating result (EBIT)/net premium earned (3) Including funds withheld End of Corporate News --------------------------------------------------------------------- 07.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Hannover Rück SE Karl-Wiechert-Allee 50 30625 Hannover Germany Phone: +49-(0)511-5604-1500 Fax: +49-(0)511-5604-1648 E-mail: info@hannover-re.com Internet: www.hannover-re.com ISIN: DE0008402215 WKN: 840 221 Indices: MDAX Listed: Regulierter Markt in Frankfurt (Prime Standard), Hannover; Freiverkehr in Berlin, Düsseldorf, Hamburg, München, Stuttgart; Terminbörse EUREX End of News DGAP News-Service --------------------------------------------------------------------- 266741 07.05.2014

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan Faces Class Action: Compliance Claims Tested

Updated Category News Views 25

An Unfolding Legal Drama for Gildan Alright, folks, it's time to dissect what's going on with Gildan Activewear, where things have taken a hard left turn into legal chaos. A class action lawsuit is shaking up the table, and let me tell you, it's got more layers than an onion. The case hinges on allegations that the company pulled a fast one with its financial controls,...

Continue Reading
Ampace Showcases Safety-First Battery Tech for AI Data Centers

Updated Category News Views 80

PU200's Debut: Making Safety and Space Work in Tandem Ever noticed how safety's become the name of the game for data center operations? Powered by the influx of AI, these digital fortresses crave robust power backup, and Ampace’s stepping in with their PU200 UPS battery solution at Data Centre World Paris 2026. Showing off at Hall 5, Booth M65, Ampace's bringing to the...

Continue Reading
Maritime Symposium Fuels Youth's Ocean Governance Aspirations

Updated Category News Views 81

Maritime Seminar Sparks Global Engagement Kicking things off, Sanya played host to a side event of the 7th Symposium on Global Maritime Cooperation and Ocean Governance, reminding everyone that the sea isn't just about waves and tides — it's a political arena too. Discussions floated around like a choppy ocean current, with more than 10 international voices weighing in....

Continue Reading
AAKP Champions Veterans' Kidney Health Initiatives

Updated Category News Views 109

Honor Through Health: AAKP's Commitment Veterans Day 2026 is a bittersweet reminder of services and sacrifices made. Enter the American Association of Kidney Patients (AAKP), the seasoned player taking Veterans' health initiatives into the limelight like an old standby pitcher braving one more inning. Their Veterans Health Initiative (VHI) isn't just a token effort—it's...

Continue Reading
AI Adoption Institute Targets ROI with Peer Circles

Updated Category News Views 73

Transforming AI from Cost to Profit Alright folks, we all know AI's the flashy tool everyone's jumping on like it's the latest tech bandwagon. But here’s the raw deal: most of these shiny AI investments ain't paying back a damn thing. Enter the AI Adoption Institute (AiAi)—a new player in Denver aiming to salvage this mess and make AI about actual returns. Peering...

Continue Reading
Group 1 Automotive Expands with Lexus Gwinnett Acquisition

Updated Category News Views 19

Unifying the Landscape: Group 1's Bold Move with Lexus Gwinnett Another piece of the puzzle drops into place as Group 1 Automotive continues its aggressive campaign to unify its dealership network. The latest acquisition sees the Hennessy Lexus of Gwinnett rebranded as Lexus Gwinnett, adding another notch to their belt in the bustling Atlanta-market corridor. Group 1's...

Continue Reading
International Tower Hill's Q3 Results: Gold Updates

Updated Category News Views 90

An Eye on International Tower Hill's Latest Moves You've got International Tower Hill Mines (TSX: ITH, NYSE American: THM) laying their cards on the table for the third quarter. This ain't just any routine check-in—it's a glimpse at their Livengood Gold Project, standing tall on the promise of gold beyond the horizon. A cool $106 million in cash? Not too shabby, folks....

Continue Reading
Elisa and Sensofusion Launch Joint Drone Venture in Europe

Updated Category News Views 56

A Match Made Beneath the Clouds Woke up today thinking about the bizarre world of drones, and it looks like Elisa Corporation and Sensofusion Plc are paving a new path in the skies of Europe. The two firms have locked hands to form Masthead Oy, aimed at creating a bird’s-eye defense mechanism to manage the unruly swarm of drones buzzing around Finland and Estonia. The...

Continue Reading
Terra-Gen's $950M Lockhart Facility Powers California

Updated Category News Views 75

A New Giant in California's Solar Landscape Out in California's desert, Terra-Gen has flipped the switch on something pretty colossal: the $950 million Lockhart Solar and Storage Project. Picture this—a solar beast boasting 538.7 MW of capacity, primed to light up around 350,000 homes and businesses. That's not just flipping a light switch; that's sparking a fire that...

Continue Reading
Align's Innovative Transporter Revolutionizes Engine Assembly

Updated Category News Views 84

Align's Game-Changer in Engine Manufacturing Let's face it, the world of heavy-duty equipment isn't always filled with breakthroughs. But every once in a while, a game-changer rolls off the line, and that's what's happening with Align Production Systems. They've crafted a custom omnidirectional transporter that does more than just move bulky engine assemblies; it...

Continue Reading

Top 5 Most Recently Viewed Articles

Alterity Therapeutics Accelerates Development of ATH434 Drug

Updated Category News Views 225

Overview of ATH434 and Fast Track Designation Alterity Therapeutics, a leading biotechnology company dedicated to developing treatments for neurodegenerative conditions, has made significant strides with its candidate, ATH434. The U.S. FDA has recently granted Fast Track designation, marking a pivotal moment in advancing the treatment of Multiple System Atrophy (MSA)....

Continue Reading
WuXi Biologics Achieves GMP Certification for Quality Assurance

Updated Category News Views 245

WuXi Biologics Earns GMP Certification for Facilities WuXi Biologics, a prominent player in the Contract Research, Development, and Manufacturing Organization (CRDMO) sector, proudly shared news of its recent achievement: the successful GMP certification of three of its cutting-edge manufacturing facilities. This certification, awarded by Türkiye ?laç ve T?bbi Cihaz...

Continue Reading
Wirex Limited Names Chet Shah CEO to Accelerate Innovation

Updated Category News Views 282

Wirex Limited Welcomes Chet Shah as New CEO Wirex Limited, a leading regulated payments platform based in the UK, has recently named Chet Shah as its new Chief Executive Officer. Chet has been a vital part of the team for the past three transformative years, serving as the Chief Risk & Compliance Officer. His vast experience and dedication played a crucial role in...

Continue Reading
KOORUI to Launch Groundbreaking 750Hz Monitor at CES 2025

Updated Category News Views 178

KOORUI to Launch Groundbreaking 750Hz Monitor at CES 2025 As a leader in the display industry, KOORUI is preparing to showcase its latest innovations at CES 2025. Attendees will have the chance to visit KOORUI at Booth #35609 in South Hall 2 of the Las Vegas Convention Center and experience firsthand the cutting-edge technology that defines the future of displays....

Continue Reading
Iris Energy Limited Faces Securities Investigation Over Claims

Updated Category News Views 88

Iris Energy Limited Under Investigation for Class Action Claims The Rosen Law Firm, a well-known advocate for investor rights, has launched an investigation into potential securities claims that could impact shareholders of Iris Energy Limited (NASDAQ: IREN). This inquiry comes in light of serious allegations that Iris Energy may have provided misleading information about...

Continue Reading